民族医药治疗类风湿关节炎的研究概览
本文综述了民族医药治疗类风湿关节炎(RA)的研究现状,检索Pubmed、CNKI和万方数据库1996至2024年文献。研究发现藏药、苗药、壮药、蒙药、傣药和回药使用药材较多且研究报道较多,治疗以复方为主,非药物疗法也有涉及,但现有民族医药仍需更多机制、药理毒理及临床研究。
要点
- 民族医药治疗RA以复方为主,单味药使用较少。
- 藏药、苗药、壮药、蒙药、傣药和回药的研究报道较多。
- 民族医药具有多成分、多靶点、整体调节且毒副作用较小的特点。
核心结论
- 民族医药治疗RA以复方为主,藏药、苗药、壮药、蒙药、傣药和回药研究报道较多,但仍需更多机制与临床研究。
研究设计与样本
- 综述检索Pubmed、CNKI和万方数据库1996至2024年文献,检索词包括中医、民族医药、关节炎、类风湿关节炎及各民族药名。
- 利用临床诊疗知识库和中药基本信息系统-药智数据补充所收集民族药的缺失基础信息。
主要发现
- 民族药物治疗RA具有多成分、多靶点、整体调节的特点,且毒副作用较小。
- 治疗RA的民族医药中,藏药、苗药、壮药、蒙药、傣药和回药使用药材较多且研究报道较多。
- 其他民族医药使用药材较少、研究报道较少或甚至没有。
- RA治疗无论实验或临床研究,均以复方为主,单味药使用较少,并涉及非药物疗法。
临床怎么用
- 民族医药可作为RA治疗的补充选择,但应基于现有研究证据合理使用复方。
- 未来研究可关注民族医药的机制探索及药理毒理和临床研究。
局限性
- 缺乏对现有民族医药治疗RA的全面概述。
- 仍需更多机制研究以及药理、毒理和临床研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rheumatoid arthritis (RA) is a common clinical autoimmune disease, characterized by persistent synovitis, cartilage destruction and systemic complications, and the incidence of which is increasing every year. The current study found that the characteristics of multi-component, multi-target, and overall regulation of ethnic drugs have significant effects on the prevention and treatment of RA, with less toxicity and side effects. However, there is a lack of comprehensive overview of existing ethnic medicine treatments for RA. This paper summarizes the available ethnomedicines for RA and reviews the current status of research on ethnomedicines against RA, experimental and clinical studies on some common ethnomedicines for RA, and the effects of non-pharmacological treatments on RA. First of all, the search terms "Chinese medicine," "traditional Chinese medicine," "ethnomedicine," "arthritis," "rheumatoid arthritis," "Mongolian medicine," "Zhuang medicine," "Miao medicine" and "Tibetan medicine" were used as search terms to search for relevant literature using Pubmed, China National Knowledge Internet (CNKI) and Wanfang data (1996-2024); secondly, the missing basic information of ethnomedicine collected was supplemented using two databases, namely, Clinical Diagnosis and Treatment Knowledge Base and the Basic Information Base of Chinese Herbal Medicine-Yaozhi data. Among the national medicines for the treatment of RA, the Tibetan medicine, Miao medicine, Zhuang medicine, Mongolian medicine, Dai medicine and Hui medicine are mostly used in the majority of medicinal materials, and the research reports are also in the majority. Other national medicines are also available, but the medicinal materials used are less, the research reports are less, or even not. The treatment of RA, whether experimental or clinical research, is mainly based on compound prescriptions, less use of single herbs, and non-drug therapy. This may provide drug selection and insights for the future experimental and clinical research directions of ethnic drugs widely used in the treatment of RA. Nevertheless, there is still a need for more mechanism research and exploration, as well as pharmacological, toxicological and clinical research on existing or untapped ethnomedicines.
引用
- Lei XJ, Sun HM, Qu YX, et al. Research overview of ethnic medicines for the treatment of rheumatoid arthritis. Front Pharmacol. 2025. PMID: 41064452. doi:10.3389/fphar.2025.1662130
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。